HLA-DQ Gene Polymorphisms Associated with Hepatitis B Virus in Patients with Hepatocellular Carcinoma Progression
- 5 April 2021
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 17 (1) , 75-81
Abstract
Background & Aims: The main cause of chronic hepatitis is Hepatitis B virus (HBV). The progression and development of hepatitis B related diseases are included liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Human leukocyte antigen-(HLA) DQ polymorphism has been observed in other recent studies dealing with the association between HBV and liver disease. Our study of Egyptian population was introduced to assess the strong association between HLA-DQ polymorphism and HBV infection in addition to the progression of HCC. The aim of this work was to estimate HLA-DQ gene polymorphisms in HBV and HCC. Methods: HLA-DQ genotype polymorphism assayed by using the ABI Taq Man allelic discrimination assay in different groups under this study. According to the relevant HLA Class II SNP literature, one single nucleotide polymorphism (SNPs) was selected as candidate sites; it is an HLA-DQ, which showed minor allele frequency AA, GA, and GG. Results: We performed haplotype analysis to all subjects, the most frequent AA haplotype in HCC cases (18%) in comparison with HBV and healthy individuals (3%). The haplotype GA was more frequent in HCC group and slightly frequency in LC related to HBV only cases in comparison with the control group. In contrast, the GG haplotype recorded less frequently in HCC individuals, but the HBV and LC groups showed more frequency in comparison with HCC group. There is a correlation between AFP serum elevated levels of most frequency in GA and AA polymorphism for HCC cases. Conclusion: We found AA and GA haplotype were significantly most frequent in HCC. Our findings HLA-DQ AA and GG polymorphism might serve as a novel potential predictive marker for HCC and may function in tumorigenesis of HBV.Keywords
This publication has 24 references indexed in Scilit:
- HLA‐DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapyJournal of Viral Hepatitis, 2013
- Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future PerspectivesSeminars in Oncology, 2012
- A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese populationHuman Molecular Genetics, 2011
- The Global Epidemiology of Hepatocellular Carcinoma: Present and FutureClinics in Liver Disease, 2011
- Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?Journal of Gastroenterology and Hepatology, 2011
- A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese populationBreast Cancer Research and Treatment, 2010
- Hepatocellular carcinoma in the Asia pacific regionJournal of Gastroenterology and Hepatology, 2009
- Human Non-synonymous Single Nucleotide Polymorphisms Can Influence Ubiquitin-mediated Protein DegradationOMICS: A Journal of Integrative Biology, 2007
- RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 Gene Polymorphisms are not Associated with the Outcome of Hepatitis B Virus Infection: Results from a Large Scale Single Ethnic PopulationJournal of Korean Medical Science, 2007
- Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness†Hepatology, 2005